{
    "nct_id": "NCT04773392",
    "official_title": "SIMPLE Study: A Prospective and Randomized Trial of a Simplified Immunosuppressive Protocol Utilizing Low Dose EnvarsusXR",
    "inclusion_criteria": "* De- Novo Kidney transplant patients between 18 and 85 years old\n* Cold ischemia time (CIT) < 24 hours for 3-6 HLA mismatches between donor and recipient and CIT >24 hours for HLA mismatch of less than 3 between donor and recipient\n* Most recent pre-transplant cPRA (calculated panel reactive antibody) â‰¤ 20%\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 85 Years",
    "exclusion_criteria": "* Repeat kidney transplant recipients\n* cPRA >20%\n* rATG (rabbit anti-thymocyte globulin) induction >6mg/kg at time of induction\n* Crossmatches deemed positive by accepting physician\n* Presence of pre-formed anti-HLA (anti-Human Leukocyte Antigen) DSA (Donor-Specific Antibody) as defined by MFI (mean fluorescence intensity) approaching 3000 using flow cytometry/Luminex-based, specific anti-HLA antibody testing.\n* Receipt of desensitization protocols\n* History of skin cancer\n* Recipient of multi-organ or dual kidney transplants\n* For any condition, in which the investigator's opinion makes the subject unsuitable for study",
    "miscellaneous_criteria": ""
}